多项指标联检对肿瘤和炎症性胸水的鉴别诊断及其临床意义  

作　　者：李之珍[1] 胡晓武[1] 

机构地区：[1]安徽省马鞍山市市人民医院检验科,243000

出　　处：《中国实用医药》2010年第11期76-77,共2页China Practical Medicine

摘　　要：目的探讨多项目联合检测在炎性胸水和恶性胸水中的诊断与鉴别诊断价值。方法采用放射免疫检测技术,检测炎性胸水和恶性胸水中癌胚抗原、β2微球蛋白、铁蛋白的含量,同时检测血液中的含量,并用SPS之S统计软件进行统计学分析处理。结果恶性胸水中CEA、SF显著高于炎性胸水,P<0.01;而β2-MG则低于炎性胸水,P<0.01;恶性胸水、炎性胸水患者血清中CEA、β2-MG均高于正常组,而SF无差别。结论CEA、β2-MG、SF的联合检测有助于恶性胸水与炎性胸水的诊断和鉴别诊断。Objective To discusse the diagnosis and the distinction diagnosis value for multi-indicators joint examination in the inflammation chest water and the malignant chest water.Methods APPlying the radioimmunassay technology to examine cancer embryo antigen,beta 2-microglobin,and ferrtin Protein in the inflammation chest water and the malignant chest water meanwhile examining the contents in the blood,and analysis Processing them with S P S S.Results Finally in the malignant chest water CEA,SF remarkably are higher than the inflammation chest water,P〈0.01;But beta 2-MG is lower than the inflammation chest water,P〈0.01;The malignant chest water,in the inflammation chest flood blood serum CEA,beta 2-MG is higher than the normal grouP,but SF no significance.Conclusion CEA,beta 2-MG,the SF joint examination is helPful to diagnosis and the distinction diagnosis for malignant chest water and the inflammation chest water.

关 键 词：胸水 癌胚抗原 Β2微球蛋白 铁蛋白 

分 类 号：R730.4[医药卫生—肿瘤] R561[医药卫生—临床医学]